Mild covid 19 symptoms and treatment as per AIIMS new Guidelines

• The All India Institute of Medical Sciences (AIIMS) and Indian Council of Medical Research (ICMR) have combinedly issued new guidelines for treatment of mild, moderate and severe cases of COVID-19.
• In case of mild COVID-19, AIIMS guidelines recommend home isolation and care.
• For full details, check out the list below.

The All India Institute of Medical Sciences (AIIMS) and Indian Council of Medical Research (ICMR) have combinedly issued new guidelines to identify COVID-19 treatment based on three levels of seriousness – mild, moderate and severe.

With COVID-19 cases exploding across India and hospitals facing acute shortage of oxygen and other critical requirements, it’s important for you to keep a track of your health, and identify COVID-19 symptoms early.

Treatment of mild COVID-19 cases

In case you have a mild case of COVID-19, you can avoid the trip to the hospital and take care of yourself at home. Here’s what the new AIIMS guidelines suggest:

How to identify

A patient is said to have mild COVID-19 in case they have upper respiratory tract symptoms and/or fever without shortness of breath or hypoxia.

Hypoxia means there is a shortage of adequate supply of oxygen at the tissue level. It can be identified by checking SpO2 levels using an oximeter.

SpO2 levels should be between 92% to 98%, anything lower than 92% is considered as hypoxia.

Suggestions

AIIMS guidelines suggest home isolation and care.

MUST DO

• Physical distancing, indoor mask use and strict hand hygiene.
• Symptomatic management (hydration, antipyretics, antitussive, multivitamins).
• Stay in contact with the treating physician.
• Monitor temperature and oxygen saturation (by applying a SpO2 probe to fingers).

Seek immediate medical attention if:

• Difficulty in breathing.
• High grade fever/severe cough, particularly if it lasts for more than five days.
• A low threshold to be kept for those with any of the high-risk features.

MAY DO

Note that these therapies are based on low certainty of evidence.

• Tab Ivermectin (200 mcg/kg once a day for 3 days). Avoid in case of pregnant and lactating women.

OR

• Tab HCQ (400 mg twice for 1 day, followed by 400 mg once daily for 4 days) unless contraindicated.

Inhalational Budesonide (given via Metered dose inhaler/ Dry powder inhaler) at a dose of 800 mcg twice for five days) to be given if symptoms (fever and/or cough) are persistent beyond five days of disease onset.

SEE ALSO:

If the COVID-19 vaccine prices are too high for some, then why not use direct benefit transfer

The COVID-19 crisis in India is getting worse with state administrations trying to hoard oxygen

There is a virtual lockdown in the world’s fourth largest automobile market